Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Revaly Reviews & Ratings
    7 Ratings
    Company Website
  • AthenaHQ Reviews & Ratings
    34 Ratings
    Company Website
  • Checksum.ai Reviews & Ratings
    1 Rating
    Company Website
  • wp2print Reviews & Ratings
    23 Ratings
    Company Website
  • Pipedrive Reviews & Ratings
    10,300 Ratings
    Company Website
  • SciSure Reviews & Ratings
    298 Ratings
    Company Website
  • JDisc Discovery Reviews & Ratings
    27 Ratings
    Company Website
  • SDS Manager Reviews & Ratings
    4 Ratings
    Company Website
  • Concord Reviews & Ratings
    237 Ratings
    Company Website
  • Cloverleaf Reviews & Ratings
    189 Ratings
    Company Website

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

What is NVIDIA BioNeMo?

BioNeMo is a cloud-based platform designed for drug discovery that harnesses artificial intelligence and employs NVIDIA NeMo Megatron to enable the training and deployment of large biomolecular transformer models at an impressive scale. This service provides users with access to pre-trained large language models (LLMs) and supports multiple file formats pertinent to proteins, DNA, RNA, and chemistry, while also offering data loaders for SMILES to represent molecular structures and FASTA for sequences of amino acids and nucleotides. In addition, users have the flexibility to download the BioNeMo framework for local execution on their own machines. Among the notable models available are ESM-1, which is based on Meta AI’s state-of-the-art ESM-1b, and ProtT5, both fine-tuned transformer models aimed at protein language tasks that assist in generating learned embeddings for predicting protein structures and properties. Furthermore, the platform will incorporate OpenFold, an innovative deep learning model specifically focused on forecasting the 3D structures of new protein sequences, which significantly boosts its capabilities in biomolecular exploration. Overall, this extensive array of tools establishes BioNeMo as an invaluable asset for researchers navigating the complexities of drug discovery in modern science. As such, BioNeMo not only streamlines research processes but also empowers scientists to make significant advancements in the field.

Media

Media

Integrations Supported

Amazon Web Services (AWS)
Evo 2
Google Cloud Platform
Microsoft Azure
NVIDIA AI Foundations
NVIDIA Clara
NVIDIA NeMo Megatron
Python

Integrations Supported

Amazon Web Services (AWS)
Evo 2
Google Cloud Platform
Microsoft Azure
NVIDIA AI Foundations
NVIDIA Clara
NVIDIA NeMo Megatron
Python

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Company Facts

Organization Name

NVIDIA

Date Founded

1993

Company Location

United States

Company Website

www.nvidia.com/en-us/gpu-cloud/bionemo/

Categories and Features

Categories and Features

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio

Popular Alternatives

ESMFold2 Reviews & Ratings

ESMFold2

Biohub
ESMC Reviews & Ratings

ESMC

Biohub
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA